BR9-24733-13717
3 vaccinations
5 coded responses
33 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 782 / TX
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
-
2020-12-28
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Mild muscle soreness at injection site when I lift my armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-29
Survey response — days 1–6 daily, dose 1MedDRA: Headache, Sinus pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: The headache feels like sinus pain, likely due to the weather change.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-03
- 2021-01-04
- 2021-01-18
-
2021-01-25
Dose 2 — Moderna
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, VomitingAdult check-in
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
-
2021-02-10
Survey response — day 14, dose 2MedDRA: SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: GoodFree text: I have NOT had any further s/e or COVID symptoms. However, I had a POS rapid antigen test 16 days (2/4/21) after 2nd dose and two subsequently NEG PCR tests.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-04-26
-
2021-07-26
Survey response — 6 months, dose 2MedDRA: Brain fog, Lacrimation increased, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold for 7 days last week - sneezing, watery eyes, runny nose, congestion, foggy brain.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-10
Dose 3 — ModernaCo-administered: Flu
-
2021-11-16
Survey response — days 1–6 daily, dose 3MedDRA: Arthralgia, Rash, Rash erythematous — Feeling: GoodFree text: Joint/aching pain for about 24 hours following the 3rd dose; on day 2, experienced red rash on face, neck and both shoulders. No urticaria present.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-17
- 2021-12-22
- 2022-02-09
- 2022-05-13
- 2022-11-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-25 | Moderna | |
| 3 | 2021-11-10 | Moderna | Flu |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Mild muscle soreness at injection site when I lift my arm
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): The headache feels like sinus pain, likely due to the weather change.
Release 4 — day 14, dose 2
Symptoms: I have NOT had any further s/e or COVID symptoms. However, I had a POS rapid antigen test 16 days (2/4/21) after 2nd dose and two subsequently NEG PCR tests.
Release 9 — 6 months, dose 2
Symptoms: Cold for 7 days last week - sneezing, watery eyes, runny nose, congestion, foggy brain.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Joint/aching pain for about 24 hours following the 3rd dose; on day 2, experienced red rash on face, neck and both shoulders. No urticaria present.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | ✓ | · | ✓ |
| SD | Lacrimation increased | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Rash erythematous | · | · | ✓ |
| SRO | Sensitivity to weather change | ○ | ○ | ○ |
| SRO | Sinus pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release